HLT:PA:PA-Lyxor Index Fund - Lyxor STOXX Europe 600 Healthcare UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 147.584

Change

-2.74 (-1.82)%

Market Cap

USD 0.77B

Volume

2.50K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.02 (+0.05%)

USD 63.50B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+2.30 (+0.41%)

USD 12.35B
WRD:PA HSBC ETFs Public Limited Compa..

+0.10 (+0.29%)

USD 10.45B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+0.03 (+0.01%)

USD 8.60B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+0.75 (+0.15%)

USD 8.46B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.37 (+0.38%)

USD 7.00B
HHH:PA HSBC ETFs Public Limited Compa..

+0.25 (+0.43%)

USD 6.90B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.06 (+0.31%)

USD 6.43B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.93 (+0.48%)

USD 5.51B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.31 (+0.19%)

USD 4.88B

ETFs Containing HLT:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.47% 51% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.47% 51% F 63% D
Trailing 12 Months  
Capital Gain 12.39% 45% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.39% 45% F 61% D-
Trailing 5 Years  
Capital Gain 41.44% 64% D 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.44% 64% D 74% C
Average Annual (5 Year Horizon)  
Capital Gain 8.45% 56% F 59% D-
Dividend Return 8.45% 53% F 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.49% 74% C 86% B+
Risk Adjusted Return 99.51% 89% A- 93% A
Market Capitalization 0.77B 77% C+ 77% C+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike